Given that intrahepatic cholangiocellular carcinoma falls under the category of rare diseases, resulting in a naturally low patient count, there is a pressing need for further studies to investigate potential gender-specific biological mechanisms underlying ALDH1A1 expression in iCC. This evidence concerns the gene ALDH1A1 and cholangiocarcinoma.